ProCE Banner Activity

ABCSG-18: Effect of Adjuvant Denosumab on DFS in Postmenopausal Women With Early HR+ Breast Cancer

Slideset Download
Conference Coverage
Adjuvant denosumab increased DFS in AI-treated postmenopausal women with early HR+ breast cancer.

Released: December 13, 2015

Expiration: December 11, 2016

No longer available for credit.

Share

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech BioOncology

Novartis Pharmaceuticals Corporation